LT-002-158 tablets
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for LT-002-158 tablets, covering 2025-02-19 to 2025-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis [Phase 1, Phase 2]